Who has invested in Innervace?

Deerfield Management, IP Group, Inc., Penn Medicine, WARF Ventures, BioAdvance are named among the investors backing Innervace.

Innervace Funding: $40M Raised, Series A (2022)

Innervace funding overview

Innervace is based in New York, New York. Innervace has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2022. The round record for Innervace runs through 2022; nothing later has been disclosed. Investors on record include Deerfield Management, IP Group, Inc., Penn Medicine, WARF Ventures, BioAdvance. 5 distinct backers are named across the disclosed rounds.

Innervace at a glance

Total raised: $40M
Latest round: Series A
Latest round date: September 2022
Headquarters: New York, New York
Notable investors: Deerfield Management, IP Group, Inc., Penn Medicine, WARF Ventures, BioAdvance

Frequently asked about Innervace funding

How much has Innervace raised?: Innervace has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Innervace?: Deerfield Management, IP Group, Inc., Penn Medicine, WARF Ventures, BioAdvance are named among the investors backing Innervace.
What was the latest Innervace funding round?: The most recent disclosed round is a Series A, announced in September 2022.
Where is Innervace based?: Innervace is based in New York, New York.
When did Innervace last raise?: The last disclosed Innervace round closed in September 2022 at Series A.

Innervace totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York below to benchmark round size and investor mix.

Innervace Funding: $40M Raised, Series A (2022)

Innervace funding overview

Innervace at a glance

Frequently asked about Innervace funding

Companies related to Innervace (36)

Browse related funding lists (6)